Table VIII.
Quality assessment of articles using Cochrane criteria
Cochrane criteria | Chun et al., 2016 | Chowers et al., 2015 | Bessesen et al., 2013 | Hassan et al., 2007 | Montecalvo et al., 2001 | van Rijen et al., 2009 |
Wassenberg et al., 2011 |
---|---|---|---|---|---|---|---|
1. Is the study population clearly described? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
2. Are competing alternatives clearly described? | No | Yes | Yes | No | No | No | Yes |
3. Is a well-defined research question posed in answerable form? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
4. Is the economic study design appropriate to the stated objective? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
5. Is the chosen time horizon appropriate to include relevant costs and consequences? | Moderate | Yes | No | No | No | Yes | Yes |
6. Is the actual perspective chosen appropriate? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
7. Are all important and relevant costs for each alternative identified? | Yes | Yes | Yes | Moderate | Yes | Yes | Yes |
8. Are all costs measured appropriately in physical units? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
9. Are costs valued appropriately? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
10. Are all important and relevant outcomes for each alternative identified? | Moderate | Moderate | Yes | Moderate | Moderate | Moderate | Yes |
11. Are all outcomes measured appropriately? | Yes | No | Yes | Moderate | Yes | Yes | Yes |
12. Are outcomes valued appropriately? | Yes | No | Yes | Yes | Yes | Yes | No |
13. Is an incremental analysis of costs and outcomes of alternatives performed? | Yes | Yes | Moderate | Moderate | Moderate | Moderate | No |
14. Are all future costs and outcomes discounted appropriately? | No | No | No | No | No | No | No |
15. Are all important variables, whose values are uncertain, appropriately subjected to sensitivity analysis? | Yes | Yes | No | No | No | No | No |
16. Do the conclusions follow from the data reported? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
17. Does the study discuss the generalizability of the results to other settings and patient/client groups? | No | Yes | Moderate | Yes | Moderate | Yes | Moderate |
18. Does the article indicate that there is no potential conflict of interest of study researcher(s) and funder(s)? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
19. Are ethical and distributional issues discussed appropriately? | Yes | Yes | No | No | No | No | No |
Overall assessment | |||||||
High | 14 (73.7%) | 15 (78.9%) | 13 (68.4%) | 10 (52.6%) | 11 (57.9%) | 13 (68.4%) | 13 (68.4%) |
Moderate | 2 (10.5%) | 1 (5.3%) | 2 (10.5%) | 4 (21.1%) | 3 (15.8%) | 2 (10.5%) | 1 (5.3%) |
Low | 3 (15.8%) | 3 (15.8%) | 4 (21.1%) | 5 (26.3%) | 5 (26.3%) | 4 (21.1%) | 5 (26.3%) |